BLISSGVS
Bliss GVS Pharma Limited
Pharmaceuticals
Share price
₹641
Market cap
₹6,842 Cr
1Y return
▲ 297%
A pharmaceutical manufacturer engaged in producing and marketing a diverse range of formulations including suppositories, pessaries, capsules, tablets, and syrups. The company operates across manufacturing, marketing, trading, and export functions, serving both domestic and international markets. Established in 1984, it has developed specialized expertise in multiple dosage forms and maintains an integrated operation across the pharmaceutical value chain to address varied healthcare requirements.
Investors holding Bliss GVS Pharma Limited
1.99%
1.53%
Recent moves 9
1newest move
Members onlyLICDecreased
LIC cut its stake in Bliss GVS Pharma from 3.24% to 1.53%, selling 18,16,071 shares.
Read more
Mates Visa Consultancy Private LimitedNew position
Mates Visa Consultancy Private Limited acquired 5,09,84,595 shares of Bliss GVS Pharma Limited, representing a 47.95% stake, pursuant to a Share Purchase Agreement.
Read more
LICDecreased
LIC sold 21,32,071 shares of Bliss GVS Pharma in the open market, decreasing its stake from 5.11% to 2.96%.
Read more
Quadrature Capital Vector SpExited
Quadrature Capital Vector Sp, which last held a 1.23 percent stake in Bliss GVS Pharma Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in their holding to below the 1 percent disclosure threshold.
Read more
360 ONE AIFNew position
360 ONE AIF entered Bliss GVS Pharma with 12,30,285 shares, a 1.16% stake.
Read more
LICDecreased
LIC decreased its stake in Bliss GVS Pharma from 4.33% to 3.24%, selling 1,137,703 shares.
Read more
Ms. Punita SharmaDecreased
Promoter Ms. Punita Sharma sold 24,962 shares of Bliss GVS Pharma for ₹72 lakh at ₹287.40 apiece, reducing her stake from 0.02% to 0.00% and fully exiting.
Read more
Gagan Harsh SharmaDecreased
Gagan Harsh Sharma, a promoter of Bliss GVS Pharma, sold 2,17,123 shares for ₹6.24 crore at ₹287.40 apiece in an open market transaction, reducing his stake from 0.21% to 0.00% and fully exiting his position.
Read more
Track the whales in Bliss GVS Pharma Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1